| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8440979 | European Journal of Cancer | 2016 | 12 Pages |
Abstract
uPA/PAI-1 testing could allow the selection of patients older than 50 years requiring chemotherapy in this population, but the cost effectiveness of this strategy is uncertain. Chemotherapy for all patients is the most cost-effective strategy for patients younger than 50 years.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sophie Marguet, Chafika Mazouni, Bram L.T. Ramaekers, Ariane Dunant, Ronald Kates, Volker R. Jacobs, Manuela A. Joore, Nadia Harbeck, Julia Bonastre,